Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02586857 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT02586857 · ClinicalTrials.gov record · last posted 2026-03-25

A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)

Name: A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM) — clinical trial record (NCT02586857)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 1/2

SponsorAcerta Pharma BV

Started2016-01-25

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

A Phase 1b/2, Multicenter, Open-Label Study of ACP-196 in Subjects with Recurrent Glioblastoma Multiforme (GBM)

Amendment record 28 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 28 times since 2015-10-23; most recent amendment 2026-03-23. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2018-06-27

Status change Recruiting→Active, Not Recruitingv6

2016-02-03

Status change Not Yet Recruiting→Recruitingv1

Trial Details

NCT Number	NCT02586857
Lead Sponsor	Acerta Pharma BV
Conditions	Glioblastoma Multiforme
Enrollment	24 participants
Start Date	2016-01-25
Primary Completion	2020-06-26 (estimated)
Study Completion	2026-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-25